CorMedix Inc. (CRMD) Financials
Key financial figures for CorMedix Inc. (Q2 2026).
CorMedix Inc. reported revenue of $101.9 million for Q2 FY2026, up 156.5% from the same period a year earlier. Net income was $26.0 million, or $0.29 per share. Operating margin came to 42.1%, against 49.18% a year earlier. Across the last 5 reported quarters, quarterly revenue has risen from $39.7 million in Q2 FY2025 to $101.9 million in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for CorMedix Inc. are on the SentiSense financials page.
- Revenue
- $102M
- Net Income
- $26M
- EPS
- $0.33
- Total Assets
- $904M
- Operating Cash Flow
- $86M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $102M | $26M | $0.29 | 42.1% | |
| Q1 FY2026 | $127M | $39M | $0.43 | 49.96% | $42M |
| Q4 FY2025 | $129M | $14M | $0.15 | 45.97% | $93M |
| Q3 FY2025 | $104M | $109M | $1.26 | 49.24% | $30M |
| Q2 FY2025 | $40M | $20M | $0.28 | 49.18% | $30M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $312M | $163M | $2.04 | 48.17% | $173M |
| FY2024 | $43M | -$18M | -$0.30 | -51.43% | -$51M |
| FY2023 | $0 | -$46M | -$0.91 | -$39M |
Frequently asked questions
What was CorMedix Inc.'s revenue last quarter?
CorMedix Inc. reported revenue of $101.9 million for Q2 FY2026, up 156.5% from the same period a year earlier.
Is CorMedix Inc. profitable?
Yes. CorMedix Inc. reported net income of $26.0 million for Q2 FY2026, a net margin of 25.5% on revenue.
How has CorMedix Inc.'s margin trended?
Operating margin was 42.1% in Q2 FY2026, compared with 49.18% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How many quarters of CorMedix Inc. financials does SentiSense hold?
SentiSense holds up to forty quarters and twenty fiscal years of income statement, balance sheet and cash flow history for CRMD. The 5 most recent quarters are summarised above.
Full income statement, balance sheet and cash flow for CorMedix Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.